Gangliosides as antigens of human melanoma
- 1 January 1988
- book chapter
- Published by Springer Nature
- Vol. 43, 17-43
- https://doi.org/10.1007/978-1-4613-1751-7_2
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Gangliosides from human melanoma immunomodulate response of T cells to interleukin-2Cellular Immunology, 1988
- Ganglioside gm2 as a target structure recognized by human natural killer cellsJournal of Clinical Laboratory Analysis, 1987
- Expression of Heterophile, Paul-Bunnell and Hanganutziu-Deicher Antigens on Human Melanoma Cell LinesInternational Archives of Allergy and Immunology, 1987
- GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progressionFEBS Letters, 1986
- Reactivity of mouse monoclonal antibody M2590 against B16 melanoma cells with chemically synthesized GM3 gangliosideBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Mouse monoclonal antibodies with specificity for the melanoma-associated ganglioside disialyllactosylceramide (GD3) also react with the structural analogue disialylparaglobosideBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1985
- Distribution of the ganglioside GD3 in the human nervous system detected by R24 mouse monoclonal antibodyBrain Research, 1984
- Gangliosides of normal and neoplastic human melanocytesBiochemical and Biophysical Research Communications, 1984
- Leukemic cells sensitive or resistant to β‐interferon have identical ganglioside patternsFEBS Letters, 1982
- Alteration of gangliosides in plasma and red cells of humans bearing melanoma tumorsBiochemical and Biophysical Research Communications, 1978